New York – September 20, 2023- Research Nester’s recent market research analysis on “Subdermal Contraceptive Implant Market: Global Demand Analysis & Opportunity Outlook 2036” delivers a detailed competitors analysis and a detailed overview of the global subdermal contraceptive implant market in terms of market segmentation by product, type, application, and by region.

Growing Awareness about Sexual Health to Promote Global Market Share of Subdermal Contraceptive Implant
The global subdermal contraceptive implant market is estimated to grow majorly on account of the increasing knowledge about sexual health. One major factor contributing to the rise in early pregnancies is a lack of accurate information on safe sex, STIs, and STDs therefore, campaigns for sexual health education and awareness are crucial, especially for young people to understand how to use effective contraceptive techniques. Over time, the world's understanding of sexual health has changed as a result young individuals interested in sexual health concerns have developed a sizable social media network that is expanding nationally. This has led to an increase in the adoption of subdermal contraceptive implants as they are highly effective implants to prevent unwanted pregnancies.

Request Free Sample Copy of this Report @ https://www.researchnester.com/sample-request-5300

The global subdermal contraceptive implant market is estimated to grow majorly on account of the increasing usage of contraceptive procedures. The use of contraception may be enhanced by expanding the use of existing methods, and increasing the efficacy and consistency of contraceptive methods which might help lower the high incidence of early and unplanned pregnancy and thus, the need for abortion.

Some of the major growth factors and challenges that are associated with the growth of the global subdermal contraceptive implant market are:

Growth Drivers:
• Surge in Importance of Family Planning Globally
• Rising Unwanted Pregnancies

Challenges:
The rising concern for adverse effects associated with subdermal contraceptive implants, and the lack of education about sexual health are some of the major factors anticipated to hamper the global market size of subdermal contraceptive implants. Menstrual irregularities, headaches, weight gain, pain at the implant site, neuropathy, and follicular cysts are a few of the side effects that some people suffer after getting implants that are used to prevent pregnancy. Additionally, these implants might result in severe headaches, confusion, and a major pregnancy problem (ectopic pregnancy).

By product, the global subdermal contraceptive implant market is segmented into etonogestrel implant, and levonorgestrel implant. The levonorgestrel implant segment is to garner a notable revenue by the end of 2036 by growing at a significant CAGR over the forecast period. Levonorgestrel- 6-capsule subdermal implants are long-acting contraceptives, approved for over 4 years of continuous use, and are said to be up to 99.95% effective at preventing pregnancy.

Request for customization @ https://www.researchnester.com/customized-reports-5300

By region, the Europe subdermal contraceptive implant market is to generate the highest revenue by the end of 2036. This growth is anticipated by the availability of free contraception procedures. The European Union has allocated over USD 20 million to provide free contraception in France under which a variety of contraceptive methods, including IUDs, birth control pills, and contraceptive implants, as well as medical consultations, tests, or other procedures related to obtaining birth control to women under the age of 25. As a result, the demand for subdermal contraceptive implants is expected to increase in the region.

In addition, European women are typically aware of long-acting reversible contraceptives because the European Parliament and the European Council have passed various regulations emphasizing the need of sexuality education which has led to increase in awareness for of long-acting contraception implants including subdermal contraceptive implants in the region.

Besides this, the subdermal contraceptive implants market in the Asia Pacific is estimated to hold a significant share by the year 2036. To reduce the growth rate of China's enormous population the country has started encouraging the use of family planning and birth control which has freed women from the burden of having several children after marriage and carrying a large family. As a result, women in China started using contraceptive implants including subdermal contraceptive implants. Apart from this, the availability of implants to the general public has been extremely beneficial for women in nations like Thailand, Bangladesh, and Indonesia, leading to higher demand for such implants.

This report also provides the existing competitive scenario of some of the key players of the global subdermal contraceptive implant market which includes company profiling of Shanghai Dahua Pharmaceutical Co., Ltd, Bayer AG, Wyeth Pharmaceuticals, Baxter, Gerresheimer AG, Pfizer, Inc., Novartis AG, Schott AG, Eli Lilly and Company, Sandoz International GmbH, Terumo Corporation, Teva Pharmaceutical Industries Ltd., and others.

Access our detailed report @ https://www.researchnester.com/reports/subdermal-contraceptive-implants-market/5300

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.

Contact for more Info:
AJ Daniel
Email: [email protected]
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919